FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Sun Pharmaceutical Industries Budesonide Inhalation Suspension Recall

Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Sin…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jun 17, 2026
Recall ID
D-0607-2026
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Budesonide Inhalation Suspension starting May 29, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0607-2026 on Jun 17, 2026. Reason: Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution. Status: Ongoing.

Why it was recalled

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Product description

Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Baska Ujeti Road, Ujeti Halol-289350, Gujarat, India, NDC 47335-633-49.

Lot numbers, UPCs & expiration codes

Lot #: BAG0074A, Exp. Date: 1/31/2027.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0607-2026
Classification
Class II
Status
Ongoing
Recall initiated
May 29, 2026
FDA report date
Jun 17, 2026
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0607-2026, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
99113
Address
2 Independence Way
Code information
Lot #: BAG0074A, Exp. Date: 1/31/2027.
Postal code
08540-6620
Report date
Jun 17, 2026
Product type
Drugs
Recall number
D-0607-2026
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Reason for recall
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
Voluntary / mandated
Voluntary: Firm initiated
Product description
Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Baska Ujeti Road, Ujeti Halol-289350, Gujarat, India, NDC 47335-633-49.
Distribution pattern
Nationwide within the United States
Recall initiation date
May 29, 2026
Initial firm notification
Letter
Center classification date
Jun 18, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0607-2026, published Jun 17, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls